BioRem Inc. (CVE:BRM – Get Free Report)’s share price traded down 1.2% during mid-day trading on Friday . The company traded as low as C$3.40 and last traded at C$3.40. Approximately 14,692 shares traded hands during mid-day trading, a decline of 40% from the average session volume of 24,302 shares. The stock had previously closed at C$3.44.
BioRem Stock Performance
The stock has a 50-day simple moving average of C$3.49 and a 200-day simple moving average of C$3.12. The stock has a market cap of C$55.10 million, a PE ratio of 10.12 and a beta of 0.74. The company has a debt-to-equity ratio of 14.17, a current ratio of 2.04 and a quick ratio of 1.08.
Insider Activity
In other news, Director Derek Webb sold 28,700 shares of the firm’s stock in a transaction on Monday, August 24th. The shares were sold at an average price of C$3.82, for a total value of C$109,634.00. Following the transaction, the director owned 362,370 shares of the company’s stock, valued at approximately C$1,384,253.40. This trade represents a 7.34% decrease in their position. 1.90% of the stock is owned by insiders.
BioRem Company Profile
BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs. The company also provides multi-stage systems to remove odors from various municipal/urban wastewater treatment processes; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems.
Featured Stories
- Five stocks we like better than BioRem
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
- 2 Stocks Breaking Out Post-FOMC With One Thing in Common
- Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.
